These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 26314479)

  • 1. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis.
    Singh S; Venkatesh SK; Loomba R; Wang Z; Sirlin C; Chen J; Yin M; Miller FH; Low RN; Hassanein T; Godfrey EM; Asbach P; Murad MH; Lomas DJ; Talwalkar JA; Ehman RL
    Eur Radiol; 2016 May; 26(5):1431-40. PubMed ID: 26314479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
    Hsu C; Caussy C; Imajo K; Chen J; Singh S; Kaulback K; Le MD; Hooker J; Tu X; Bettencourt R; Yin M; Sirlin CB; Ehman RL; Nakajima A; Loomba R
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):630-637.e8. PubMed ID: 29908362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data.
    Singh S; Venkatesh SK; Wang Z; Miller FH; Motosugi U; Low RN; Hassanein T; Asbach P; Godfrey EM; Yin M; Chen J; Keaveny AP; Bridges M; Bohte A; Murad MH; Lomas DJ; Talwalkar JA; Ehman RL
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):440-451.e6. PubMed ID: 25305349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
    Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
    J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
    Zhang YN; Fowler KJ; Boehringer AS; Montes V; Schlein AN; Covarrubias Y; Wolfson T; Hong CW; Valasek MA; Andre MP; Loomba R; Sirlin CB
    Eur Radiol; 2022 Apr; 32(4):2457-2469. PubMed ID: 34854929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
    Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
    J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis.
    Singh S; Venkatesh SK; Keaveny A; Adam S; Miller FH; Asbach P; Godfrey EM; Silva AC; Wang Z; Murad MH; Asrani SK; Lomas DJ; Ehman RL
    Ann Hepatol; 2016; 15(3):363-76. PubMed ID: 27049490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy.
    Liang Y; Li D
    BMC Gastroenterol; 2020 Apr; 20(1):89. PubMed ID: 32252641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J
    AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842
    [No Abstract]   [Full Text] [Related]  

  • 10. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
    Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort.
    Lara Romero C; Liang JX; Fernández Lizaranzazu I; Ampuero Herrojo J; Castell J; Del Prado Alba C; Domínguez Pascual I; Romero Gómez M
    Rev Esp Enferm Dig; 2023 Apr; 115(4):162-167. PubMed ID: 35791792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.
    Loomba R; Cui J; Wolfson T; Haufe W; Hooker J; Szeverenyi N; Ang B; Bhatt A; Wang K; Aryafar H; Behling C; Valasek MA; Lin GY; Gamst A; Brenner DA; Yin M; Glaser KJ; Ehman RL; Sirlin CB
    Am J Gastroenterol; 2016 Jul; 111(7):986-94. PubMed ID: 27002798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease.
    Ajmera VH; Liu A; Singh S; Yachoa G; Ramey M; Bhargava M; Zamani A; Lopez S; Mangla N; Bettencourt R; Rizo E; Valasek M; Behling C; Richards L; Sirlin C; Loomba R
    Hepatology; 2020 Mar; 71(3):849-860. PubMed ID: 31556124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
    Jung J; Loomba RR; Imajo K; Madamba E; Gandhi S; Bettencourt R; Singh S; Hernandez C; Valasek MA; Behling C; Richards L; Fowler K; Sirlin CB; Nakajima A; Loomba R
    Gut; 2021 Oct; 70(10):1946-1953. PubMed ID: 33214165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.
    Hanniman E; Costa AF; Bowen CV; Abdolell M; Stueck A; McLeod M; Peltekian K; Rioux J; Clarke SE
    J Magn Reson Imaging; 2022 Nov; 56(5):1448-1456. PubMed ID: 35285996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.
    Qu Y; Middleton MS; Loomba R; Glaser KJ; Chen J; Hooker JC; Wolfson T; Covarrubias Y; Valasek MA; Fowler KJ; Zhang YN; Sy E; Gamst AC; Wang K; Mamidipalli A; Schwimmer JB; Song B; Reeder SB; Yin M; Ehman RL; Sirlin CB
    Eur Radiol; 2021 Nov; 31(11):8408-8419. PubMed ID: 33899143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
    Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
    Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis.
    Sangha K; Chang ST; Cheung R; Deshpande VS
    Hepatology; 2023 May; 77(5):1702-1711. PubMed ID: 37018145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD.
    Tamaki N; Imajo K; Sharpton SR; Jung J; Sutter N; Kawamura N; Yoneda M; Valasek MA; Behling C; Sirlin CB; Kurosaki M; Izumi N; Nakajima A; Loomba R
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):380-387.e3. PubMed ID: 35123096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.